Cargando…

Breast tumour stroma is a prognostic indicator and target for therapy

Detalles Bibliográficos
Autores principales:	Howell, Anthony, Landberg, Goran, Bergh, Jonas
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797696/ https://www.ncbi.nlm.nih.gov/pubmed/20030867 http://dx.doi.org/10.1186/bcr2435

Ejemplares similares

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer
por: Downey, C L, et al.
Publicado: (2014)

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)

Prognostic significance of tumour stroma ratio in inflammatory breast cancer
por: Downey, Candice L, et al.
Publicado: (2015)

Metabolic approaches to breast cancer treatment and prevention
por: Howell, Anthony
Publicado: (2007)

The emerging breast cancer epidemic: early diagnosis and treatment
por: Howell, Anthony
Publicado: (2010)

The prognostic significance of tumour-stroma ratio in endometrial carcinoma
por: Panayiotou, Hannah, et al.
Publicado: (2015)

Should lifestyle modifications be promoted to prevent breast cancer?
por: Howell, Anthony, et al.
Publicado: (2008)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
por: Di Cosimo, Serena
Publicado: (2009)

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
por: Kramer, C. J. H., et al.
Publicado: (2018)

Systematic identification of the key candidate genes in breast cancer stroma
por: Wang, Yanxia, et al.
Publicado: (2018)

Lymphatic lacunae of the human eye conjunctiva embedded within a stroma containing CD34(+) telocytes
por: Nicolescu, Mihnea I., et al.
Publicado: (2020)

GNG5 is an unfavourable independent prognostic indicator of gliomas
por: Yang, Biao, et al.
Publicado: (2020)

Gastric cancer nodal tumour–stroma ratios influence prognosis
por: Huang, J., et al.
Publicado: (2020)

Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines
por: Denner, Joachim
Publicado: (2020)

Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study
por: French, David P., et al.
Publicado: (2022)

Angiogenesis - still a worthwhile target for breast cancer therapy?
por: Lord, Simon, et al.
Publicado: (2010)

Hypoxic Signalling in Tumour Stroma
por: Laitala, Anu, et al.
Publicado: (2018)

Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
por: Roberts, Matthew J., et al.
Publicado: (2022)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

The evolution of treatment for early breast cancer: what’s next?
por: Howell, T
Publicado: (2009)

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
por: De Fonseka, Duneesha, et al.
Publicado: (2022)

Oncological resection, myasthenia gravis and staging as prognostic factors in thymic tumours: a Chilean case series
por: Salas, Patricio, et al.
Publicado: (2021)

Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?
por: Cassidy, Jim
Publicado: (2007)

Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
por: Kairaluoma, Valtteri, et al.
Publicado: (2020)

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
por: Gradilone, Angela, et al.
Publicado: (2011)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Is Height of Prognostic Significance in Breast Cancer Cases?
por: Cihan, Yasemin Benderli
Publicado: (2017)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
por: Oh, Hyeon Jeong, et al.
Publicado: (2017)

Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
por: Borgquist, Signe, et al.
Publicado: (2007)

The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis
por: Nelson, Michaela, et al.
Publicado: (2015)

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
por: Zhang, S M, et al.
Publicado: (2008)

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
por: Mego, M, et al.
Publicado: (2009)

An LC-QToF MS based method for untargeted metabolomics of human fecal samples
por: Cheng, Ken, et al.
Publicado: (2020)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado: (2023)

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
por: Micke, Patrick, et al.
Publicado: (2021)

Targeting and retention of HPV16 E7 to the endoplasmic reticulum enhances immune tumour protection
por: Loera-Arias, MJ, et al.
Publicado: (2010)

Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting
por: Kooijmans, Sander A. A., et al.
Publicado: (2016)

The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_q8r1jfpe4hv64nkicamlsthdka